Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index

 
 

On Nov. 12 Abbott (NYSE: ABT) achieved the highest score out of 84 companies in its industry in the S&P Global Corporate Sustainability Assessment, also called the Dow Jones Sustainability Index (DJSI). This was the ninth consecutive year that Abbott has secured the top score in the Health Care Equipment & Supplies sector, and the 17 th consecutive year that Abbott has been included on the Dow Jones Sustainability World Index and North America Index. The DJSI measures the performance of companies using environmental, social and governance (ESG) criteria and is considered one of the most prestigious global benchmarks for corporate sustainability.

 

Abbott's continued strong performance on the DJSI reflects the company's longstanding commitment to sustainability in health. Abbott's 2030 Sustainability Plan focuses on innovating for greater access to life-changing technologies and breaking down barriers to health equity to reach more people in more places than ever before.

 

"The emphasis of our 2030 Sustainability Plan is on the priority where we can make the greatest impact and do the most good for the most people: in focusing our future innovation on creating products that are affordable and accessible to more people than ever before," said Robert B. Ford , president and chief executive officer, Abbott. "Using our primary expertise to help the world achieve greater total health at lower total cost is the most meaningful way we can contribute to the long-term sustainability of our society and our planet."

 

Abbott scored 83 (out of 100) in the 2021 S&P Global Corporate Sustainability Assessment, achieving the highest industry score in nine of 25 total criteria, including strategy to improve access to drugs or products, health outcome contribution, social reporting, human capital development, information security/cybersecurity & systems availability, marketing practices, materiality, environmental reporting, and occupational health and safety.

 

Abbott recently released its 2020 Sustainability Report Summary , which shares its high-level global performance in key areas, including innovating for access and affordability, building the workforce of tomorrow, protecting the environment, responsibly applying data to advance care, building a more resilient supply chain, and delivering product quality and safety. For detailed information about our materiality process, policies, management approach, performance and targets for all our environmental, social and governance (ESG) priorities, see our full Global Sustainability Report .

 

For more information on the Dow Jones Sustainability Index, please see the S&P Global website and the DJSI news release .

 

To learn more about Abbott's approach to sustainability and its 2030 Sustainability Plan, please visit www.abbott.com/sustainability .

 

  About Abbott:  
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

 

Connect with us at www.abbott.com , on LinkedIn at www.linkedin.com/company/abbott-/ , on Facebook at https://www.facebook.com/Abbott and on Twitter @AbbottNews .

 

 Cision View original content: https://www.prnewswire.com/news-releases/abbott-achieves-highest-score-in-its-industry-for-the-ninth-consecutive-year-on-the-dow-jones-sustainability-index-djsi-301424215.html  

 

SOURCE Abbott

 
 

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

BlinkLab states in its Wednesday (March 12) release that the study is the largest digital diagnostic trial for autism in the US, with its aim being to support the early detection of developmental conditions like autism.

The first patient test took place at PriMED Clinical Research in Dayton, Ohio. PriMED, a division of PriMED Physicians, is one of two clinical sites selected for the study’s initial phase, which is targeting 100 patients.

Keep reading...Show less
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at enhancing remote pregnancy monitoring and expanding the range of health data available to expectant mothers and their healthcare providers.

Keep reading...Show less
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.

Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or a mix of both. Aside from stocks, some ETFs also track commodities or bonds.

In the healthcare industry, medical device ETFs bring together companies that go to great lengths to develop pharmaceutical-based technology that can improve the lives of patients.

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of Technegas® in up to 169 nuclear medicine departments across HCA’s extensive network.1

Keep reading...Show less
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence

Download the PDF here.

Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities.

The groundbreaking developments in antifungal treatments specifically targeting women's health issues present a substantial market potential, resulting in rising investor interest in this rapidly evolving sector.

Despite comprising half the global population, women face unique health challenges that have historically received insufficient attention and investment. Among these health challenges, vaginal candidiasis stands out as a persistent and widespread issue affecting millions of women worldwide.

Keep reading...Show less

Latest Press Releases

Related News

×